Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3uib | SB2 | Putative mitogen-activated protein kinase |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 1.000 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.508 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.497 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.494 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 3lfa | 1N1 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.486 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.478 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.474 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.474 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.473 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.470 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
| 2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
| 4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.464 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
| 5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.463 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.462 | |
| 2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
| 3u9e | COA | Lmo1369 protein | / | 0.462 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
| 2ft9 | CHD | Fatty acid-binding protein 2, liver | / | 0.460 | |
| 3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.460 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.459 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.459 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
| 2xsz | ATP | RuvB-like 2 | 3.6.4.12 | 0.457 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.457 | |
| 2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.456 | |
| 3uk6 | ADP | RuvB-like 2 | 3.6.4.12 | 0.456 | |
| 4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.456 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.454 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.454 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.452 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.450 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.450 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.449 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.449 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.449 | |
| 2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 3hwr | NDP | 2-dehydropantoate 2-reductase | / | 0.448 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 1u3c | FAD | Cryptochrome-1 | / | 0.447 | |
| 2zja | ACP | ATP-dependent DNA helicase Hel308 | / | 0.447 | |
| 3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.447 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.447 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.447 | |
| 1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
| 3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.444 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.444 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.444 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 1q1w | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.443 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.443 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 3ru9 | NAD | UDP-N-acetylglucosamine 4-epimerase | / | 0.443 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.443 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.443 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.442 | |
| 1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
| 2hma | SAM | tRNA-specific 2-thiouridylase MnmA | / | 0.442 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.442 | |
| 4a9r | RU5 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 4a9u | A9U | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 4xj4 | 3AT | Cyclic GMP-AMP synthase | / | 0.442 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.442 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.442 | |
| 2jcx | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.441 | |
| 2lba | CHO | Fatty acid binding protein 6 | / | 0.441 | |
| 2rkv | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.441 | |
| 3a9w | NAD | NDP-sugar epimerase | / | 0.441 | |
| 3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
| 3zpt | M8Y | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.441 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.441 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.441 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.441 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 1rdw | LAR | Actin, alpha skeletal muscle | / | 0.440 | |
| 1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.440 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.440 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.440 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.440 |